FDA Approves First Monoclonal Antibody Treatment, Librela, for Arthritis in Dogs

MONDAY, May 8, 2023 -- Man’s aging best friend has a new treatment to dull osteoarthritis pain as the U.S. Food and Drug Administration (FDA) announced approval Friday of the first monoclonal antibody for dogs.
Called Librela, the bedinvetmab...